Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Clinical trial NCT01239368 · TERMINATED
Trial details
- NCT number
- NCT01239368
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-10
- Primary completion
- 2017-08-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.